Discectomy surgery successfully relieves nerve compression in 80 to 90 percent of patients, but reherniation remains the most significant complication patients and surgeons must prepare for. In this article, we take a closer look at the documented rates of postsurgical reherniation, the patient and anatomical factors that elevate risk, and the evidence-based prevention strategies that can protect long-term outcomes.
What Is Reherniation and Why Is It the Leading Complication after Discectomy?
Reherniation occurs when residual disc material exits the intervertebral space through the annular defect left behind by surgery, compressing the nerve root a second time. It is the leading cause of reoperation after primary discectomy and represents a distinct clinical failure rather than a continuation of the original condition.
When a surgeon removes herniated disc material, the fibrous outer ring of the disc (the annulus fibrosus) retains a defect at the site of the herniation. Under standard care, that defect is left unrepaired. Any nucleus pulposus tissue remaining inside the disc space has an anatomical pathway through which it can reherniate. The result is a recurrence of radicular pain, leg weakness, or sensory loss that closely mirrors the patient’s original presenting symptoms.
Understanding reherniation as a structural and mechanical problem rather than simply a surgical failure is essential for accurately assessing risk and selecting the most appropriate preventive interventions.
How Common Is Reherniation Following Primary Discectomy Surgery?
Reherniation rates following primary discectomy are consistently reported across the literature within a range of five to 15 percent, depending on the study population, follow-up duration, and surgical technique. Lumbar microdiscectomy carries reported success rates of approximately 80 to 90 percent, but reherniation remains the leading cause of reoperation after primary discectomy.
A national cohort study with eight years of follow-up data reported a reherniation rate of approximately 6 percent following primary discectomy. Other analyses that account for longer observation windows or higher-risk subgroups report figures toward the upper end of the range.
For patients undergoing percutaneous endoscopic lumbar discectomy (PELD) specifically, a published meta-analysis found the overall prevalence of recurrent herniation after PELD was 3.6 percent, with recurrence typically occurring within six months postoperatively.
These figures underscore that reherniation is not a rare outlier event. It is a clinically meaningful complication that surgical planning and postoperative care protocols must directly address.
Why Has Microdiscectomy Become the Preferred Technique Over Traditional Open Discectomy?
Microdiscectomy has replaced traditional open discectomy as the standard of care for lumbar disc herniation because it achieves equivalent or superior clinical outcomes while producing significantly less surgical trauma. The distinction matters for complication rates: the smaller the operative footprint, the fewer the tissue disruptions that can give rise to adverse events.
Traditional open discectomy requires a longer incision and substantial retraction or removal of paraspinal muscle tissue to access the affected disc level. Microdiscectomy uses a small incision, specialized retractors, and a surgical microscope to achieve the same decompression through a far narrower corridor. The microscope provides magnified, high-contrast visualization of neural structures and disc material, allowing surgeons to remove herniated tissue precisely while preserving surrounding architecture.
The clinical evidence supporting this shift is consistent across multiple studies. A prospective cohort study of 600 patients found microdiscectomy was associated with fewer complications (14.9 percent versus 23 percent), faster mean recovery time (5.2 weeks versus 7.6 weeks), and higher patient satisfaction compared to open discectomy. A separate retrospective analysis of 396 patients reported success rates of 86.8 percent for microdiscectomy versus 77.8 percent for open discectomy, with discitis (infection of the disc space) occurring in 0.4 percent of microdiscectomy patients compared to 2.6 percent of open discectomy patients.
The advantages of the minimally invasive approach extend beyond the operating room. Reduced tissue damage translates to less postoperative pain, lower risk of epidural fibrosis, and shorter hospital stays. Patients undergoing microdiscectomy typically return to daily activities more quickly than those who have had traditional open surgery, and the reduced muscular disruption supports a more functional early recovery period.
For the overwhelming majority of patients with symptomatic lumbar disc herniation who have not responded to conservative management, microdiscectomy is now the recommended surgical intervention. Open discectomy retains a role in specific anatomical or clinical scenarios where minimally invasive access is not feasible, but it is no longer considered the default approach.
Which Patient Factors Significantly Increase the Risk of Reherniation?
Several patient-level variables are associated with elevated reherniation risk, and identifying them preoperatively allows surgeons and patients to make better-informed decisions about surgical approach and postoperative management.
A systematic review and meta-analysis published in Medicine identified three variables with statistically significant associations with recurrent lumbar disc herniation: smoking, disc protrusion, and diabetes were predictors for recurrent lumbar disc herniation, while gender, BMI, occupational work, and level or side of herniation did not reach statistical significance in that analysis.
A separate meta-analysis focused specifically on percutaneous endoscopic lumbar discectomy reinforced and expanded these findings, identifying Modic change, smoking, type 2 diabetes, sagittal range of motion, BMI, and age as significantly related to post-operative recurrence.
Across the broader literature, the consistent message is that smoking and diabetes represent modifiable risk factors: variables a patient has the ability to address before and after surgery. Older age and higher BMI represent elevated but partially modifiable risk. Disc degeneration severity and anatomical factors at the operated level add additional structural context that informs surgical decision-making.
How Does Annular Defect Size Influence the Probability of Reherniation?
Annular defect size is one of the most clinically significant surgical-level predictors of reherniation, and it is identifiable only intraoperatively. Symptom recurrence related to reherniation is reported in seven to 18 percent of lumbar discectomy patients, and patients with large versus small annular defects face significantly higher rates of symptom recurrence and reoperation (2.5 and 2.3 times higher, respectively) with the association not significantly influenced by surgery type, age, or sex.
Large annular defects are generally defined as those with a defect width of six millimeters or greater and account for approximately 30 percent of patients undergoing lumbar discectomy. The mechanism is straightforward: a larger opening in the annulus fibrosus provides a lower-resistance pathway for residual nuclear material to re-exit the disc space. Animal studies have reported that a compromised annulus fibrosus has limited intrinsic healing ability, and annular healing after discectomy occurs slowly, yielding biomechanically inferior fibrous tissue with reduced capacity to accommodate tensile force.
This means patients with large annular defects carry a structurally elevated baseline risk that persists throughout the discectomy recovery period, regardless of how well they adhere to postoperative protocols.
What Prevention Strategies Reduce the Risk of Reherniation after Discectomy?
Prevention strategies operate at two levels: the surgical level, where technique and implant selection directly influence annular integrity, and the patient level, where lifestyle modifications address modifiable risk factors.
At the surgical level, annular closure devices (ACDs) have demonstrated meaningful reductions in reherniation rates for patients with large annular defects. In a prospective, multicenter randomized controlled trial enrolling 554 patients across 21 European centers, symptomatic reherniations occurred in 1.5 percent of patients in the annular closure device group, compared to 6.5 percent in the control group. One-year post-market data on bone-anchored ACDs found a symptomatic reherniation rate of 3.7 percent in the ACD group, compared to 17.0 percent in the control group receiving discectomy alone.
At the patient level, several modifiable factors consistently appear across the literature. Smoking cessation is among the most important interventions a patient can undertake. Lack of regular physical exercise has also been identified as a significant predictor of recurrent lumbar disc herniation, alongside high BMI and physical inactivity.
Optimizing glycemic control in patients with diabetes prior to surgery also reduces systemic inflammatory burden that contributes to poor disc healing. Weight management reduces axial loading on the operated segment during the recovery window.
Postoperative physical therapy focused on core stabilization rather than early return to heavy loading supports the structural recovery of surrounding musculature without placing excessive mechanical stress on the surgical site. Patients should follow surgeon-directed restrictions on lifting, bending, and twisting during the first several months following surgery.
What Are Other Recognized Complications of Discectomy Surgery?
While reherniation is the most common significant complication, patients and referring clinicians should be familiar with the full spectrum of potential adverse outcomes.
Dural tears, or inadvertent breaches of the protective membrane surrounding the spinal cord and nerve roots, occur in a small percentage of cases and typically require intraoperative repair. When managed promptly, they rarely result in long-term neurological consequences.
Nerve root injury, though uncommon, represents one of the more serious potential complications. It can present as new or worsened motor weakness, sensory loss, or chronic neuropathic pain in the affected distribution.
Surgical site infection, while uncommon in clean spinal procedures, carries the risk of discitis (infection of the intervertebral disc space) which is a serious complication requiring extended antibiotic therapy and, in some cases, surgical debridement.
Adjacent segment disease is a longer-term consideration more commonly associated with fusion procedures, though some degree of altered biomechanical loading can occur after any structural intervention on the lumbar spine.
Frequently Asked Questions
How soon after discectomy does reherniation typically occur?
Most reherniations occur within the first six months following surgery, when the annular defect is at its most vulnerable and patients are transitioning back to daily activity levels.
Can a reherniated disc be treated without surgery?
Sometimes. Conservative management including physical therapy, anti-inflammatory medications, and epidural steroid injections is typically attempted first, though patients with significant neurological deficits or severe recurrent pain often require revision surgery.
Does the surgical technique affect reherniation risk?
Yes. Aggressive nucleus removal leaves less residual material to reherniate but accelerates disc height loss, while conservative removal preserves disc height but leaves more material available to reherniate. Annular closure device implantation reduces reherniation risk in patients with large defects.
Is a second discectomy as effective as the first?
Generally yes, though outcomes following revision discectomy are somewhat less predictable than primary surgery, with higher technical difficulty and greater risk of complications such as epidural scarring and nerve root adhesion.
What should patients tell their surgeons to minimize their reherniation risk?
Patients should disclose their smoking status, BMI, diabetes diagnosis, and physical activity level, as these directly inform risk stratification and may influence surgical planning, including the decision to use an annular closure device.
Issues such as complications and back surgery recovery time vary among individuals who have discectomies and may often depend on factors such as whether the patient has a large hole in the outer ring of the disc after surgery. Patients with a large annular defect (typically wider than approximately 6 millimeters) have a significantly higher risk of reherniation. These reherniations often require additional surgery or even a larger spinal fusion operation. Barricaid is a bone-anchored device designed to reduce the likelihood of reherniation by closing the large hole often left in the spinal disc after microdiscectomy, and 95 percent of Barricaid patients did not undergo a reoperation due to reherniation in a 2-year study timeframe. This treatment is done immediately following the discectomy—during the same operation—and does not require any additional incisions or time in the hospital.
If you have any questions about the Barricaid treatment or how to get access to Barricaid, you may ask your doctor or contact us directly.
For full benefit/risk information, please visit: https://www.barricaid.com/instructions.
Comments